P2X3 receptor antagonist (Gwangju Institute of Science & Technology/Chonnam National University/Daegu-Gyeongbuk Medical Innovation Foundation/Korea Institute of Science and Technology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameP2X3 receptor antagonist (Gwangju Institute of Science & Technology/Chonnam National University/Daegu-Gyeongbuk Medical Innovation Foundation/Korea Institute of Science and Technology)
Drug Alias NameP2X3 receptor antagonists (Gwangju Inst Sci & Tech/Chonnam National Univ/Daegu-Gyeongbuk Medical Innovation Foundation/KIST)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 3 antagonists
TargetsP2X purinoceptor 3
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGwangju Institute of Science and Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChonnam National UniversityDaegu-Gyeongbuk Medical Innovation FoundationKorea Institute Of Science And Technology +[4] 
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A